Strona glówna
•
FAQ
•
Szukaj
•
Użytkownicy
•
Grupy
•
Galerie
•
Rejestracja
•
Profil
•
Zaloguj się, by sprawdzić wiadomości
•
Zaloguj
Forum Forum MESA !! Strona Główna
->
Regulamin
Napisz odpowiedź
Użytkownik
Temat
Treść wiadomości
Emotikony
Więcej Ikon
Kolor:
Domyślny
Ciemnoczerwony
Czerwony
Pomarańćzowy
Brązowy
Żółty
Zielony
Oliwkowy
Błękitny
Niebieski
Ciemnoniebieski
Purpurowy
Fioletowy
Biały
Czarny
Rozmiar:
Minimalny
Mały
Normalny
Duży
Ogromny
Zamknij Tagi
Opcje
HTML:
TAK
BBCode
:
TAK
Uśmieszki:
TAK
Wyłącz HTML w tym poście
Wyłącz BBCode w tym poście
Wyłącz Uśmieszki w tym poście
Kod potwierdzający: *
Wszystkie czasy w strefie EET (Europa)
Skocz do:
Wybierz forum
Nabór do ZESPÓŁ Forum MESA
----------------
Nabór
MESA - DRUŻYNY
----------------
GKS Bełchatów
Cracovia Kraków
Dyskobolia Grodzisk Wielkopolski
Górnik Zabrze
Jagiellonia Białystok
Korona Kielce
Lech Poznań
Legia Warszawa
ŁKS Łódź
Odra Wodzisław Śląski
Polonia Bytom
Ruch Chorzów
Wisła Kraków
Zagłębie Lubin
Zagłębie Sosnowiec
MESA - OGÓLNIE
----------------
Regulamin
Terminarz
Sędziowie
Wyniki
DLA KIBICA
----------------
Typer
Rozrywka
Sonda
INNE
----------------
Hydepark
Reklama
PARTNERZY
----------------
Parnerzy w reklamie i realizacji projektu !!
Przegląd tematu
Autor
Wiadomość
ncycgdxhl
Wysłany: Śro 0:51, 09 Mar 2011
Temat postu: Meropenem on Gram-negative bacteria common clinica
Meropenem on Gram-negative bacteria common clinical drug sensitivity analysis
, Cephalosporins ~ ff
89.33%). 3.4B a lactam antibiotics on the production of ESBL. Strains, according to the National Committee for Clinical Laboratory Standards (NCCSL) provides that: on the production of ESBL. Klebsiella pneumoniae and Escherichia coli may be clinically Penicillium, cephalosporins, or aztreonam treatment ineffective. 3.5 Single-acyl antibiotic aztreonam ring of non-ESBL producing strains have a higher in vitro antibacterial activity against Escherichia coli sensitive to rate of 89.47% for non-ESBL producing Klebsiella pneumoniae sensitive to rate of 93 .33%. 3.6 meropenem than for imipenem of Pseudomonas aeruginosa activity. 75.29% of the sensitivity of Pseudomonas aeruginosa to meropenem, only 67.88% sensitive to imipenem of Pseudomonas aeruginosa; of Acinetobacter baumannii, the highest in vitro antibacterial activity of antibiotics were as follows: United States meropenem (97.26%), imipenem (94.03%) cefepime (89.23%), ceftazidime (89.23%), cefoperazone / sulbactam (88.89%). 4 Discussion enzyme Meropenem is a hydrocarbon vinyl antibiotics,
p90x workout calendar
, enzymes and other hydrocarbon C1 vinyl in a different methyl, can increase the stability of dehydrogenation peptidase, without combination with enzyme inhibitors, thereby reducing the renal toxicity and central nervous system responses. Meanwhile, in the C2 bit dimethyl disulfide bond aminoacyl pyrrolidine,
belstaff outlet
, increase the antibacterial activity against Gram-negative bacteria. This study shows that the middle of Enterobacteriaceae ESBL. Escherichia coli and Klebsiella pneumoniae and non-producing ESBL. Escherichia coli and Klebsiella pneumoniae,
asics australia
, meropenem and imipenem in vitro antibacterial activity of the same, sensitivity was 100%, better than the other 16 kinds of antibiotics, and reported the same. Pseudomonas aeruginosa is a common clinical conditions of pathogenic bacteria, but also 591 is the most important pathogens of nosocomial infection is one of the primary lung infection caused by bacteria L6]. The data show that meropenem against Pseudomonas aeruginosa in vitro antimicrobial activity than imipenem. Pseudomonas aeruginosa infection and a variety of therapeutic action, antibiotics and immunosuppressive treatment are closely related, and thus cause a variety of antimicrobial agents. Complex mechanism of resistance of Pseudomonas aeruginosa,
tory burch reva
, mainly produce type I membrane protein permeability cephalosporin reduced enzyme active efflux systems and mechanisms of resistance. Conditions in the past considered to be pathogenic bacteria Acinetobacter baumannii nosocomial infection in recent years has become an important pathogen, the research data of Acinetobacter baumannii, in vitro antibacterial activity of meropenem the most sensitive rate was 97.26 %,
p90x workout schedule
, better than imipenem and other antibiotics. This study shows that meropenem against Enterobacteriaceae producing ESBLs and non ESBL producing strains have a high antibacterial activity against Pseudomonas aeruginosa, Acinetobacter baumannii in vitro antibacterial activity than imipenem, so the United States meropenem can be used as clinically effective antibiotic treatment of severe infections or suspected pathogen is not clear due to resistant strains of serious infections.
fora.pl
- załóż własne forum dyskusyjne za darmo
Theme
FrayCan
created by
spleen
&
Download
Powered by
phpBB
© 2001, 2005 phpBB Group
Regulamin